Studies on the in vivo induction and suppression of direct and lectin-dependent, cell-mediated cytotoxicity

Document Type


Date of Original Version



Alloimmunization (C57BL/6, anti-P815) can result in the development of cytolytic effector cells capable of mediating direct antigen-specific, cell-mediated cytotoxicity (DCMC) and nonspecific lectin-dependent, cell-mediated cytotoxicity (LDCC). The induction of DCMC appeared to require challenge with large numbers (108) of viable replicating P815 cells, whereas LDCC reactivity was obtained following challenge with high or low (104) numbers of replicating or mitomycin C-treated P815 cells. Other alloantigen preparations, e.g., soluble antigen or membrane preparations, failed to induce DCMC or LDCC. An examination of the effects of high- and low-dose challenge using viable P815 cells demonstrated that high-dose challenge resulted in strong DCMC, LDCC, a readily detectable humoral response, and some delayed-type hypersensitivity, whereas low-dose challenge yielded LDCC, strong delayed-type hypersensitivity, and suppressor cell activity. The development of DCMC was severely suppressed in animals primed with a low-dose P815 challenge and subsequently rechallenged with 108 P815. Further development of LDCC was similarly suppressed. It appears that although both DCMC and LDCC effector cells are susceptible to previously activated suppression, during a primary in vivo response a portion of the LDCC effector cells develop beyond a critical stage before suppression is expressed. © 1980.

Publication Title, e.g., Journal

Cellular Immunology